Protein Supplement and Enhanced Recovery After Posterior Spine Fusion Surgery

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Razieh Khalooeifard ◽  
Saeed Oraee-Yazdani ◽  
Mohsen Keikhaee ◽  
Zahra Vahdat Shariatpanahi
2013 ◽  
Vol 13 (8) ◽  
pp. 877-881 ◽  
Author(s):  
Yossi Smorgick ◽  
Kevin C. Baker ◽  
Casey C. Bachison ◽  
Harry N. Herkowitz ◽  
David M. Montgomery ◽  
...  

2022 ◽  
pp. rapm-2021-103234
Author(s):  
Stephanie Pan ◽  
Charles K Lee ◽  
Thomas J Caruso ◽  
John S Vorhies ◽  
Ban C H Tsui

2018 ◽  
Vol 12 (1) ◽  
pp. 61-68 ◽  
Author(s):  
Ashraf Nabil Saleh ◽  
Raham Hasan Mostafa

Background:The inhibitory effect of Tranexamic Acid (TXA) on γ-aminobutyric acid and glycine receptors of spinal dorsal horn neurons which leads to pain arousal, has been highlighted recently in animal studies. Such findings would elicit concerns about adverse effects of TXA as a routine agent used to reduce perioperative blood loss.Objectives:This study aimed to evaluate the effect of different doses of TXA on analgesic requirements in adolescent patients undergoing elective single-stage posterior spine fusion surgery for idiopathic scoliosis.Patients and Methods:This prospective, randomized, double-blinded study comprised 75 patients who were randomly allocated to one of three groups. Each group comprised 25 patients. In group C (Control), patients received normal saline. While in group HD (High Dose), patients received TXA with a loading dose of 50 mg/kg and maintenance dose of 20 mg/kg/h and patients in group LD (Low Dose) received TXA with a loading dose of 10 mg/kg and maintenance dose of 1 mg/kg/h. The total intraoperative fentanyl dose was calculated for each patient which we used as a measure of the patients’ nociception level.Results:Group HD patients’ required the highest dose of fentanyl compared to those in LD group (mean of 60µgversus27µg). Patients in group C received no extra intraoperative narcotic doses and experienced the longest duration of surgical procedure. These results showed high statistically significant difference (p< 0.001).Conclusion:Intraoperative administration of TXA increases the analgesic requirement during elective single stage posterior spine fusion surgery which likely reflects an increase in patients’ intraoperative nociception.


2015 ◽  
Vol 15 (9) ◽  
pp. 2114-2115
Author(s):  
Yossi Smorgick ◽  
Kevin C. Baker ◽  
Jeffrey S. Fischgrund

2015 ◽  
Vol 15 (9) ◽  
pp. 2113-2114 ◽  
Author(s):  
ZhiNan Ren ◽  
Shugang Li ◽  
Shangyi Hui ◽  
Qianyu Zhuang ◽  
Xin Chen ◽  
...  

Spine ◽  
2011 ◽  
Vol 36 (22) ◽  
pp. 1867-1877 ◽  
Author(s):  
Stavros G. Memtsoudis ◽  
Vassilios I. Vougioukas ◽  
Yan Ma ◽  
Licia K. Gaber-Baylis ◽  
Federico P. Girardi

2021 ◽  
Vol 2021 ◽  
pp. 1-6
Author(s):  
Khalid AlSaleh ◽  
Khalid Murrad ◽  
Abdulmajeed AlZakri ◽  
Osama Alrehaili ◽  
Waleed Awwad

Introduction. Spine fusion surgery is an increasingly popular procedure, but the patient experience is variable and the cost is high. Enhanced recovery after surgery (ERAS) pathways can provide a standardized plan for spine fusion cases, improving quality of care and reducing costs. We report an early attempt at the implementation of such a pathway and compare it to a historical cohort. Methods. All adult patients undergoing elective posterior thoracolumbar spine fusion in 2019 and 2020 were included in the study. The ERAS protocol implementation started in January 2020. The study cohort was all cases performed in 2020—after implementation of ERAS—while the historical cohort was cases from 2019. Demographic and clinical data were collected and compared between the groups. Results. Ninety-three patients were included in the study. The study cohort (ERAS) included 42 patients, while the comparison group (pre-ERAS) included 51 patients. Demographic and preoperative clinical data were similar between the two groups. However, postoperative clinical data showed that ERAS resulted in less reliance on analgesics, earlier mobilization, and a reduced length of stay. Complication and readmission rates were unchanged. Conclusion. ERAS can reduce costs while maintaining or improving clinical outcomes for spinal fusion surgery.


10.14444/8005 ◽  
2021 ◽  
Vol 15 (1) ◽  
pp. 47-54
Author(s):  
Razieh Khalooeifard ◽  
Zahra Vahdat Shariatpanahi ◽  
Amirahmad Ahani ◽  
Mohsen Keykhaee ◽  
Maryam Oraee-Yazdani ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document